Aptiv PLC (APTV) stock
Close on Oct 29, 2026Market cap $9.23BP/E 41.9Yield –
Earnings
Aptiv's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Aptiv's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026before the open | $3.30B | -36.5% | $1.40 | $1.63 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026before the open | $5.10B | +6.3% | $0.88 | $1.71 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 2, 2026before the open | $5.20B | +6.1% | $0.64 | $1.86 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 30, 2025before the open | – | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025before the open | $5.20B | +2.0% | $1.80 | $2.12 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025before the open | $4.80B | -2.0% | -$0.05 | $1.69 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 6, 2025before the open | $4.90B | 0.0% | $1.14 | $1.75 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024before the open | $4.90B | -3.9% | $1.48 | $1.83 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024before the open | $5.10B | -1.9% | $3.47 | $1.58 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024before the open | $4.90B | +2.1% | $0.79 | $1.16 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 31, 2024before the open | $4.90B | +6.5% | $3.22 | $1.40 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $5.10B | +10.9% | $5.76 | $1.30 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $5.20B | +26.8% | $0.84 | $1.25 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023before the open | $4.80B | +14.3% | $0.54 | $0.91 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 2, 2023before the open | $4.60B | +12.2% | $0.86 | $1.27 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022before the open | $4.60B | +24.3% | $1.05 | $1.28 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022before the open | $4.10B | – | -$0.23 | $0.22 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022before the open | $4.20B | – | $0.27 | $0.63 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 3, 2022before the open | $4.10B | – | $0.06 | $0.56 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021before the open | $3.70B | – | $0.32 | $0.38 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 3, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Jul 30, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Aptiv's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | Q3 FY2026 | $3.12B – $3.22B | – | New | Aug 4, 2026 |
| Adjusted EBITDAnon-GAAP | Q3 FY2026 | $545.00M – $575.00M | – | New | Aug 4, 2026 |
| U.S. GAAP diluted net income per share from continuing operationsGAAP | Q3 FY2026 | $0.86 – $0.96 | – | New | Aug 4, 2026 |
| Adjusted net income per sharenon-GAAP | Q3 FY2026 | $1.25 – $1.35 | – | New | Aug 4, 2026 |
| Adjusted EBITDA marginnon-GAAP | Q3 FY2026 | 17.7% | – | New | Aug 4, 2026 |
| U.S. GAAP net income from continuing operationsGAAP | Q3 FY2026 | $180.00M – $200.00M | – | New | Aug 4, 2026 |
| U.S. GAAP net income from continuing operations marginGAAP | Q3 FY2026 | 6% | – | New | Aug 4, 2026 |
| Net sales | FY2026 | $12.60B – $12.80B | – | New | Aug 4, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $2.31B – $2.37B | – | New | Aug 4, 2026 |
| U.S. GAAP diluted net income per share from continuing operationsGAAP | FY2026 | $4.06 – $4.26 | – | New | Aug 4, 2026 |
| Adjusted net income per sharenon-GAAP | FY2026 | $5.60 – $5.80 | – | New | Aug 4, 2026 |
| Free cash flownon-GAAP | FY2026 | $625.00M – $725.00M | – | New | Aug 4, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2026 | 18.4% | – | New | Aug 4, 2026 |
| Adjusted effective tax ratenon-GAAP | FY2026 | 18% | – | Lowered | Aug 4, 2026 |
| Cash flow from continuing operations | FY2026 | $1.27B – $1.37B | – | New | Aug 4, 2026 |
| U.S. GAAP effective tax rateGAAP | FY2026 | 18% | – | Raised | Aug 4, 2026 |
| U.S. GAAP net income from continuing operationsGAAP | FY2026 | $860.00M – $900.00M | – | New | Aug 4, 2026 |
| U.S. GAAP net income from continuing operations marginGAAP | FY2026 | 6.9% | – | New | Aug 4, 2026 |
Guidance vs results
The last range Aptiv gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2025 | Adjusted net income per share (a) | $1.70 – $1.90 | $2.12 | Above range |
| Q2 FY2025 | EPS (GAAP) | $1.30 – $1.50 | $1.80 | Above range |
| Q2 FY2025 | Revenue | $4.92B – $5.12B | $5.20B | Above range |
| Q1 FY2025 | Adjusted net income per share (2) | $1.40 – $1.60 | $1.69 | Above range |
| Q1 FY2025 | EPS (GAAP) | $0.90 – $1.10 | -$0.05 | Below range |
| Q1 FY2025 | Revenue | $4.64B – $4.84B | $4.80B | Within range |
Guidance history
Every forecast Aptiv put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 4, 2026 | Adjusted EBITDA | FY2026 | $2.31B – $2.37B | New |
| Aug 4, 2026 | Adjusted EBITDA | Q3 FY2026 | $545.00M – $575.00M | New |
| Aug 4, 2026 | Adjusted net income per share | FY2026 | $5.60 – $5.80 | New |
| Aug 4, 2026 | Adjusted net income per share | Q3 FY2026 | $1.25 – $1.35 | New |
| Aug 4, 2026 | U.S. GAAP diluted net income per share from continuing operations | Q3 FY2026 | $0.86 – $0.96 | New |
| Aug 4, 2026 | U.S. GAAP diluted net income per share from continuing operations | FY2026 | $4.06 – $4.26 | New |
| Aug 4, 2026 | Free cash flow | FY2026 | $625.00M – $725.00M | New |
| Aug 4, 2026 | Adjusted EBITDA margin | FY2026 | 18.4% | New |
| Aug 4, 2026 | U.S. GAAP net income from continuing operations margin | FY2026 | 6.9% | New |
| Aug 4, 2026 | U.S. GAAP effective tax rate | FY2026 | 18% | Raised |
| Aug 4, 2026 | Cash flow from continuing operations | FY2026 | $1.27B – $1.37B | New |
| Aug 4, 2026 | U.S. GAAP net income from continuing operations | FY2026 | $860.00M – $900.00M | New |
| Aug 4, 2026 | U.S. GAAP net income from continuing operations margin | Q3 FY2026 | 6% | New |
| Aug 4, 2026 | Adjusted EBITDA margin | Q3 FY2026 | 17.7% | New |
| Aug 4, 2026 | U.S. GAAP net income from continuing operations | Q3 FY2026 | $180.00M – $200.00M | New |
| Aug 4, 2026 | Adjusted effective tax rate | FY2026 | 18% | Lowered |
| Aug 4, 2026 | Net sales | Q3 FY2026 | $3.12B – $3.22B | New |
| Aug 4, 2026 | Net sales | FY2026 | $12.60B – $12.80B | New |
| Jul 31, 2025 | Capital expenditures | FY2025 | $780.00M | Lowered |
| Jul 31, 2025 | Adjusted EBITDA | Q3 FY2025 | $755.00M – $805.00M | New |
| Jul 31, 2025 | Adjusted EBITDA | FY2025 | $3.14B – $3.24B | Narrowed |
| Jul 31, 2025 | Adjusted net income per share | FY2025 | $7.30 – $7.60 | Raised |
| Jul 31, 2025 | Adjusted net income per share | Q3 FY2025 | $1.60 – $1.80 | New |
| Jul 31, 2025 | U.S. GAAP diluted net income per share | Q3 FY2025 | $1.30 – $1.50 | New |
| Jul 31, 2025 | U.S. GAAP diluted net income per share | FY2025 | $4.40 – $4.70 | Lowered |
| Jul 31, 2025 | U.S. GAAP operating income | Q3 FY2025 | $440.00M – $490.00M | New |
| Jul 31, 2025 | Adjusted operating income | Q3 FY2025 | $560.00M – $610.00M | New |
| Jul 31, 2025 | U.S. GAAP operating income | FY2025 | $1.83B – $1.93B | Lowered |
| Jul 31, 2025 | Adjusted operating income | FY2025 | $2.37B – $2.47B | Narrowed |
| Jul 31, 2025 | U.S. GAAP operating income margin | Q3 FY2025 | 8.9% – 9.6% | New |
| Jul 31, 2025 | Adjusted operating income margin | Q3 FY2025 | 11.3% – 12% | New |
| Jul 31, 2025 | U.S. GAAP operating income margin | FY2025 | 9.2% – 9.5% | Lowered |
| Jul 31, 2025 | Adjusted operating income margin | FY2025 | 11.9% – 12.2% | Lowered |
| Jul 31, 2025 | U.S. GAAP net income margin | Q3 FY2025 | 5.9% – 6.5% | New |
| Jul 31, 2025 | Adjusted EBITDA margin | Q3 FY2025 | 15.3% – 15.8% | New |
| Jul 31, 2025 | U.S. GAAP net income | Q3 FY2025 | $290.00M – $330.00M | New |
| Jul 31, 2025 | U.S. GAAP net income margin | FY2025 | 4.9% – 5.1% | Lowered |
| Jul 31, 2025 | U.S. GAAP effective tax rate | FY2025 | 35% | Raised |
| Jul 31, 2025 | Adjusted EBITDA margin | FY2025 | 15.7% – 15.9% | Lowered |
| Jul 31, 2025 | Adjusted effective tax rate | FY2025 | 17.5% | Raised |
| Jul 31, 2025 | Cash flow from operations | FY2025 | $2.00B | Lowered |
| Jul 31, 2025 | U.S. GAAP net income | FY2025 | $975.00M – $1.05B | Lowered |
| Jul 31, 2025 | Net sales | Q3 FY2025 | $4.95B – $5.10B | New |
| Jul 31, 2025 | Net sales | FY2025 | $20.00B – $20.30B | Narrowed |
| May 1, 2025 | Capital expenditures | FY2025 | $880.00M | Reaffirmed |
| May 1, 2025 | Adjusted EBITDA | Q2 FY2025 | $735.00M – $795.00M | New |
| May 1, 2025 | Adjusted EBITDA | FY2025 | $3.10B – $3.28B | Reaffirmed |
| May 1, 2025 | Adjusted net income per share (a) | Q2 FY2025 | $1.70 – $1.90 | New |
| May 1, 2025 | Adjusted net income per share (a) | FY2025 | $7.00 – $7.60 | Reaffirmed |
| May 1, 2025 | U.S. GAAP diluted net income per share (a) | Q2 FY2025 | $1.30 – $1.50 | New |
| May 1, 2025 | U.S. GAAP diluted net income per share (a) | FY2025 | $5.25 – $5.85 | Reaffirmed |
| May 1, 2025 | U.S. GAAP operating income | Q2 FY2025 | $400.00M – $460.00M | New |
| May 1, 2025 | Adjusted operating income | Q2 FY2025 | $545.00M – $605.00M | New |
| May 1, 2025 | U.S. GAAP operating income | FY2025 | $1.86B – $2.04B | Reaffirmed |
| May 1, 2025 | Adjusted operating income | FY2025 | $2.33B – $2.51B | Reaffirmed |
| May 1, 2025 | U.S. GAAP operating income margin | Q2 FY2025 | 8.1% – 9% | New |
| May 1, 2025 | Adjusted operating income margin | Q2 FY2025 | 11.1% – 11.8% | New |
| May 1, 2025 | U.S. GAAP operating income margin | FY2025 | 9.5% – 10% | Reaffirmed |
| May 1, 2025 | Adjusted operating income margin | FY2025 | 11.9% – 12.3% | Reaffirmed |
| May 1, 2025 | U.S. GAAP net income margin | Q2 FY2025 | 5.7% – 6.3% | New |
| May 1, 2025 | Adjusted EBITDA margin | Q2 FY2025 | 14.9% – 15.5% | New |
| May 1, 2025 | U.S. GAAP net income | Q2 FY2025 | $280.00M – $320.00M | New |
| May 1, 2025 | U.S. GAAP net income margin | FY2025 | 6% – 6.5% | Lowered |
| May 1, 2025 | U.S. GAAP effective tax rate | FY2025 | 17.5% | Raised |
| May 1, 2025 | Adjusted EBITDA margin | FY2025 | 15.8% – 16.1% | Lowered |
| May 1, 2025 | Adjusted effective tax rate | FY2025 | 17.5% | Raised |
| May 1, 2025 | Cash flow from operations | FY2025 | $2.10B | Reaffirmed |
| May 1, 2025 | U.S. GAAP net income | FY2025 | $1.18B – $1.32B | Reaffirmed |
| May 1, 2025 | Net sales | Q2 FY2025 | $4.92B – $5.12B | New |
| May 1, 2025 | Net sales | FY2025 | $19.60B – $20.40B | Reaffirmed |
| Feb 6, 2025 | Capital expenditures | FY2025 | $880.00M | New |
| Feb 6, 2025 | Adjusted EBITDA | Q1 FY2025 | $685.00M – $735.00M | New |
| Feb 6, 2025 | Adjusted EBITDA | FY2025 | $3.10B – $3.28B | New |
| Feb 6, 2025 | Adjusted net income per share (2) | Q1 FY2025 | $1.40 – $1.60 | New |
| Feb 6, 2025 | Adjusted net income per share (2) | FY2025 | $7.00 – $7.60 | New |
| Feb 6, 2025 | U.S. GAAP diluted net income per share | Q1 FY2025 | $0.90 – $1.10 | New |
| Feb 6, 2025 | U.S. GAAP diluted net income per share | FY2025 | $5.25 – $5.85 | New |
| Feb 6, 2025 | U.S. GAAP operating income | Q1 FY2025 | $360.00M – $410.00M | New |
| Feb 6, 2025 | Adjusted operating income | Q1 FY2025 | $495.00M – $545.00M | New |
| Feb 6, 2025 | U.S. GAAP operating income | FY2025 | $1.86B – $2.04B | New |
| Feb 6, 2025 | Adjusted operating income | FY2025 | $2.33B – $2.51B | New |
| Feb 6, 2025 | U.S. GAAP operating income margin | Q1 FY2025 | 7.8% – 8.5% | New |
| Feb 6, 2025 | Adjusted operating income margin | Q1 FY2025 | 10.7% – 11.3% | New |
| Feb 6, 2025 | U.S. GAAP operating income margin | FY2025 | 9.5% – 10% | New |
| Feb 6, 2025 | Adjusted operating income margin | FY2025 | 11.9% – 12.3% | New |
| Feb 6, 2025 | U.S. GAAP net income margin | Q1 FY2025 | 4.6% – 5.3% | New |
| Feb 6, 2025 | Adjusted EBITDA margin | Q1 FY2025 | 14.8% – 15.2% | New |
| Feb 6, 2025 | U.S. GAAP net income | Q1 FY2025 | $215.00M – $255.00M | New |
| Feb 6, 2025 | U.S. GAAP net income margin | FY2025 | 6% – 6.5% | New |
| Feb 6, 2025 | U.S. GAAP effective tax rate | FY2025 | 17.5% | Raised |
| Feb 6, 2025 | Adjusted EBITDA margin | FY2025 | 15.8% – 16.1% | New |
| Feb 6, 2025 | Adjusted effective tax rate | FY2025 | 17.5% | Raised |
| Feb 6, 2025 | Cash flow from operations | FY2025 | $2.10B | New |
| Feb 6, 2025 | U.S. GAAP net income | FY2025 | $1.18B – $1.32B | New |
| Feb 6, 2025 | Net sales | Q1 FY2025 | $4.64B – $4.84B | New |
| Feb 6, 2025 | Net sales | FY2025 | $19.60B – $20.40B | New |
| Oct 31, 2024 | Capital expenditures | FY2024 | $875.00M | New |
| Oct 31, 2024 | Adjusted EBITDA | FY2024 | $3.03B – $3.13B | Lowered |
| Oct 31, 2024 | Adjusted net income per share (1) | FY2024 | $6.00 – $6.30 | Lowered |
| Oct 31, 2024 | U.S. GAAP diluted net income per share | FY2024 | $6.80 – $7.10 | Lowered |
| Oct 31, 2024 | U.S. GAAP operating income | FY2024 | $1.77B – $1.87B | Lowered |
| Oct 31, 2024 | Adjusted operating income | FY2024 | $2.30B – $2.40B | Lowered |
| Oct 31, 2024 | U.S. GAAP operating income margin | FY2024 | 9% – 9.4% | Lowered |
| Oct 31, 2024 | Adjusted operating income margin | FY2024 | 11.7% – 12.1% | Lowered |
| Oct 31, 2024 | U.S. GAAP net income margin | FY2024 | 8.9% – 9.2% | Lowered |
| Oct 31, 2024 | U.S. GAAP effective tax rate | FY2024 | 10.6% | Raised |
| Oct 31, 2024 | Adjusted EBITDA margin | FY2024 | 15.4% – 15.7% | Lowered |
| Oct 31, 2024 | Adjusted effective tax rate | FY2024 | 16.5% | Raised |
| Oct 31, 2024 | Cash flow from operations | FY2024 | $2.15B | New |
| Oct 31, 2024 | U.S. GAAP net income | FY2024 | $1.74B – $1.84B | Lowered |
| Oct 31, 2024 | Net sales | FY2024 | $19.60B – $19.90B | New |
| Aug 1, 2024 | Capital expenditures | FY2024 | $900.00M | Lowered |
| Aug 1, 2024 | Adjusted EBITDA | FY2024 | $3.11B – $3.21B | Lowered |
| Aug 1, 2024 | Adjusted net income per share | FY2024 | $6.15 – $6.45 | Raised |
| Aug 1, 2024 | U.S. GAAP diluted net income per share | FY2024 | $7.00 – $7.30 | New |
| Aug 1, 2024 | U.S. GAAP operating income | FY2024 | $1.86B – $1.96B | New |
| Aug 1, 2024 | Adjusted operating income | FY2024 | $2.38B – $2.48B | Lowered |
| Aug 1, 2024 | U.S. GAAP operating income margin | FY2024 | 9.3% – 9.6% | New |
| Aug 1, 2024 | Adjusted operating income margin | FY2024 | 11.8% – 12.1% | Raised |
| Aug 1, 2024 | U.S. GAAP net income margin | FY2024 | 8.9% – 9.3% | New |
| Aug 1, 2024 | U.S. GAAP effective tax rate | FY2024 | 11.6% | Raised |
| Aug 1, 2024 | Adjusted EBITDA margin | FY2024 | 15.4% – 15.7% | Lowered |
| Aug 1, 2024 | Adjusted effective tax rate | FY2024 | 16.5% | Raised |
| Aug 1, 2024 | U.S. GAAP net income | FY2024 | $1.79B – $1.89B | Lowered |
| Aug 1, 2024 | Cash flow from operations | FY2024 | $2.15B | Raised |
| Aug 1, 2024 | Net sales | FY2024 | $20.10B – $20.40B | Lowered |
| May 2, 2024 | Capital expenditures | FY2024 | $1.00B | Lowered |
| May 2, 2024 | Adjusted EBITDA | FY2024 | $3.15B – $3.30B | Lowered |
| May 2, 2024 | Adjusted net income per share | FY2024 | $5.80 – $6.30 | Raised |
| May 2, 2024 | Adjusted operating income | FY2024 | $2.43B – $2.58B | Lowered |
| May 2, 2024 | Adjusted operating income margin | FY2024 | 11.6% – 12% | Reaffirmed |
| May 2, 2024 | Adjusted EBITDA margin | FY2024 | 15.1% – 15.4% | Lowered |
| May 2, 2024 | Adjusted effective tax rate | FY2024 | 17.5% | Raised |
| May 2, 2024 | Cash flow from operations | FY2024 | $2.35B | Raised |
| May 2, 2024 | Net sales | FY2024 | $20.85B – $21.45B | Lowered |
| Jan 31, 2024 | Capital expenditures | FY2024 | $1.05B | New |
| Jan 31, 2024 | Adjusted EBITDA | FY2024 | $3.20B – $3.35B | New |
| Jan 31, 2024 | Adjusted net income per share | FY2024 | $5.55 – $6.05 | New |
| Jan 31, 2024 | Adjusted operating income | FY2024 | $2.48B – $2.63B | New |
| Jan 31, 2024 | Adjusted operating income margin | FY2024 | 11.6% – 12% | New |
| Jan 31, 2024 | Adjusted EBITDA margin | FY2024 | 15% – 15.3% | New |
| Jan 31, 2024 | Adjusted effective tax rate | FY2024 | 17.5% | Raised |
| Jan 31, 2024 | Cash flow from operations | FY2024 | $2.30B | New |
| Jan 31, 2024 | Net sales | FY2024 | $21.30B – $21.90B | New |
| Nov 2, 2023 | Capital expenditures | FY2023 | $950.00M | Reaffirmed |
| Nov 2, 2023 | Adjusted EBITDA | FY2023 | $2.76B – $2.86B | Reaffirmed |
| Nov 2, 2023 | Adjusted net income per share | FY2023 | $4.60 – $4.90 | Reaffirmed |
| Nov 2, 2023 | Adjusted operating income | FY2023 | $2.08B – $2.18B | Reaffirmed |
| Nov 2, 2023 | Adjusted operating income margin | FY2023 | 10.4% – 10.7% | Reaffirmed |
| Nov 2, 2023 | Adjusted EBITDA margin | FY2023 | 13.8% – 14.1% | Raised |
| Nov 2, 2023 | Adjusted effective tax rate | FY2023 | 12.5% | Lowered |
| Nov 2, 2023 | Cash flow from operations | FY2023 | $2.00B | Reaffirmed |
| Nov 2, 2023 | Net sales | FY2023 | $19.95B – $20.25B | Reaffirmed |
| Aug 3, 2023 | Capital expenditures | FY2023 | $950.00M | Reaffirmed |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $2.76B – $2.86B | Raised |
| Aug 3, 2023 | Adjusted net income per share | FY2023 | $4.60 – $4.90 | Raised |
| Aug 3, 2023 | Adjusted operating income | FY2023 | $2.08B – $2.18B | Raised |
| Aug 3, 2023 | Adjusted operating income margin | FY2023 | 10.4% – 10.7% | Narrowed |
| Aug 3, 2023 | Adjusted EBITDA margin | FY2023 | 13.8% – 14.1% | Lowered |
| Aug 3, 2023 | Adjusted effective tax rate | FY2023 | 12.5% | Lowered |
| Aug 3, 2023 | Cash flow from operations | FY2023 | $2.00B | Raised |
| Aug 3, 2023 | Net sales | FY2023 | $19.95B – $20.25B | Raised |
| May 4, 2023 | Capital expenditures | FY2023 | $950.00M | Reaffirmed |
| May 4, 2023 | Adjusted EBITDA | FY2023 | $2.59B – $2.75B | Reaffirmed |
| May 4, 2023 | Adjusted net income per share | FY2023 | $4.00 – $4.50 | Reaffirmed |
| May 4, 2023 | Adjusted operating income | FY2023 | $1.92B – $2.08B | Reaffirmed |
| May 4, 2023 | Adjusted operating income margin | FY2023 | 10.3% – 10.8% | Reaffirmed |
| May 4, 2023 | Adjusted EBITDA margin | FY2023 | 13.8% – 14.2% | Lowered |
| May 4, 2023 | Adjusted effective tax rate | FY2023 | 14.5% | Raised |
| May 4, 2023 | Cash flow from operations | FY2023 | $1.90B | Reaffirmed |
| May 4, 2023 | Net sales | FY2023 | $18.70B – $19.30B | Reaffirmed |
| Feb 2, 2023 | Capital expenditures | FY2023 | $950.00M | New |
| Feb 2, 2023 | Adjusted EBITDA | FY2023 | $2.59B – $2.75B | New |
| Feb 2, 2023 | Adjusted net income per share | FY2023 | $4.00 – $4.50 | New |
| Feb 2, 2023 | Adjusted operating income | FY2023 | $1.92B – $2.08B | New |
| Feb 2, 2023 | Adjusted operating income margin | FY2023 | 10.3% – 10.8% | New |
| Feb 2, 2023 | Adjusted EBITDA margin | FY2023 | 13.8% – 14.2% | New |
| Feb 2, 2023 | Adjusted effective tax rate | FY2023 | 14.5% | Raised |
| Feb 2, 2023 | Cash flow from operations | FY2023 | $1.90B | New |
| Feb 2, 2023 | Net sales | FY2023 | $18.70B – $19.30B | New |
| Nov 3, 2022 | Capital expenditures | FY2022 | $800.00M | Lowered |
| Nov 3, 2022 | Adjusted EBITDA | FY2022 | $2.16B – $2.31B | Reaffirmed |
| Nov 3, 2022 | Adjusted net income per share | FY2022 | $3.05 – $3.55 | Reaffirmed |
| Nov 3, 2022 | Adjusted operating income | FY2022 | $1.53B – $1.68B | Reaffirmed |
| Nov 3, 2022 | Adjusted operating income margin | FY2022 | 9% – 9.7% | Reaffirmed |
| Nov 3, 2022 | Adjusted EBITDA margin | FY2022 | 12.7% – 13.4% | Raised |
| Nov 3, 2022 | Adjusted effective tax rate | FY2022 | 13% | Narrowed |
| Nov 3, 2022 | Cash flow from operations | FY2022 | $1.35B | Lowered |
| Nov 3, 2022 | Net sales | FY2022 | $17.00B – $17.30B | Reaffirmed |
| Aug 4, 2022 | Capital expenditures | FY2022 | $800.00M | New |
| Aug 4, 2022 | Adjusted EBITDA | FY2022 | $2.16B – $2.31B | Lowered |
| Aug 4, 2022 | Adjusted net income per share (1) | FY2022 | $3.05 – $3.55 | Lowered |
| Aug 4, 2022 | Adjusted operating income | FY2022 | $1.53B – $1.68B | Lowered |
| Aug 4, 2022 | Adjusted operating income margin | FY2022 | 9% – 9.7% | Lowered |
| Aug 4, 2022 | Adjusted EBITDA margin | FY2022 | 12.7% – 13.4% | Raised |
| Aug 4, 2022 | Adjusted effective tax rate | FY2022 | 13% | Narrowed |
| Aug 4, 2022 | Cash flow from operations | FY2022 | $1.53B | Lowered |
| Aug 4, 2022 | Net sales | FY2022 | $17.00B – $17.30B | Lowered |
| May 5, 2022 | Capital expenditures | FY2022 | $850.00M | Reaffirmed |
| May 5, 2022 | Adjusted EBITDA | FY2022 | $2.42B – $2.70B | Reaffirmed |
| May 5, 2022 | Adjusted net income per share (1) | FY2022 | $3.90 – $4.80 | Reaffirmed |
| May 5, 2022 | Adjusted operating income | FY2022 | $1.75B – $2.03B | Reaffirmed |
| May 5, 2022 | Adjusted operating income margin | FY2022 | 9.9% – 11.2% | Reaffirmed |
| May 5, 2022 | Adjusted EBITDA margin | FY2022 | 13.6% – 14.8% | Raised |
| May 5, 2022 | Adjusted effective tax rate | FY2022 | 13% | Lowered |
| May 5, 2022 | Cash flow from operations | FY2022 | $2.05B | Reaffirmed |
| May 5, 2022 | Net sales | FY2022 | $17.75B – $18.15B | Reaffirmed |
| Feb 3, 2022 | Capital expenditures | FY2022 | $850.00M | New |
| Feb 3, 2022 | Adjusted EBITDA | FY2022 | $2.42B – $2.70B | New |
| Feb 3, 2022 | Adjusted net income per share | FY2022 | $3.90 – $4.80 | New |
| Feb 3, 2022 | Adjusted operating income | FY2022 | $1.75B – $2.03B | New |
| Feb 3, 2022 | Adjusted operating income margin | FY2022 | 9.9% – 11.2% | New |
| Feb 3, 2022 | Adjusted EBITDA margin | FY2022 | 13.6% – 14.8% | New |
| Feb 3, 2022 | Adjusted effective tax rate | FY2022 | 13% | Lowered |
| Feb 3, 2022 | Cash flow from operations | FY2022 | $2.05B | New |
| Feb 3, 2022 | Net sales | FY2022 | $17.75B – $18.15B | New |
| Nov 4, 2021 | Capital expenditures | FY2021 | $650.00M | New |
| Nov 4, 2021 | Adjusted EBITDA | FY2021 | $1.94B – $2.09B | New |
| Nov 4, 2021 | Adjusted net income per share (1) | FY2021 | $2.30 – $2.80 | New |
| Nov 4, 2021 | Adjusted operating income | FY2021 | $1.15B – $1.30B | New |
| Nov 4, 2021 | Adjusted operating income margin | FY2021 | 7.6% – 8.4% | New |
| Nov 4, 2021 | Adjusted EBITDA margin | FY2021 | 12.8% – 13.5% | New |
| Nov 4, 2021 | Adjusted effective tax rate | FY2021 | 12% | Lowered |
| Nov 4, 2021 | Cash flow from operations | FY2021 | $1.23B | New |
| Nov 4, 2021 | Net sales | FY2021 | $15.10B – $15.50B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Aptiv filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- News
- News
- News
- News
- News
- News
- Results
- Update
- Results
- Results
- Results
- Results